DiaMedica Therapeutics Inc. Prepaid Expense, Current
DiaMedica Therapeutics Inc. (DMAC) had Prepaid Expense, Current of $94.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-19.
Discontinued › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2024-03-19
- 2023-12-31: Prepaid Expense, Current $94.00K.
- 2023-09-30: Prepaid Expense, Current $396.00K.
- 2023-06-30: Prepaid Expense, Current $616.00K.
- 2023-03-31: Prepaid Expense, Current $870.00K.
| Period end | Prepaid Expense, Current |
|---|---|
| 2023-12-31 | $94.00K 10-K · filed 2024-03-19 |
| 2023-09-30 | $396.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $616.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $870.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $209.00K 10-K · filed 2024-03-19 |
| 2021-12-31 | $84.00K 10-K · filed 2023-03-28 |
| 2018-12-31 | $369.00K 10-K · filed 2019-03-19 |
| 2017-12-31 | $61.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |